Search CDMOs

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Integrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities.

• CMC Analytical Development
• Cartridge Filling
• CMC Regulatory Submission Support

Independent CDMO specialist in aseptic fill-finish, drug product development, analytical services, and combination product assembly with 76 years of experience and 7,300+ employees globally.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Global CDMO offering cell line development, process and analytical development, formulation development, and clinical and commercial manufacturing for mammalian and microbial biologics.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development

Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Cartridge Filling

Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

• AAV Manufacturing
• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development

Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.

• CMC Analytical Development
• Cell-Line Development
• CMC Regulatory Submission Support

GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Italian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.

• CMC Analytical Development
• CMC Regulatory Submission Support
• mRNA Manufacturing

Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Bioconjugation Services

Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Formulation Development

Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.

• AAV Manufacturing
• Cell Therapy Manufacturing
• Downstream Processing

Integrated CDMO platform combining proprietary enzymatic synthetic DNA production with advanced therapy development and GMP manufacturing for mRNA, gene editing, viral vectors, cell therapies, and vaccines.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Cold-Chain Storage & Logistics

Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.